A novel pathogenic RFXANK variant causing MHC class II deficiency in two unrelated patients from Mexico
Authors:
- Maria Enriqueta Nuñez-NuñezMNMaria Enriqueta Nuñez-Nuñez
- Juan Carlos Bustamante-OgandoJBJuan Carlos Bustamante-Ogando
- Beatriz Bayardo-GutierrezBBBeatriz Bayardo-Gutierrez
- Juan Carlos Lona-ReyesJLJuan Carlos Lona-Reyes
- Emma Valeria Estrada-ArceEEEmma Valeria Estrada-Arce
- Saul O. Lugo-ReyesSLSaul O. Lugo-Reyes
- Sara Elva Espinosa-PadillaSESara Elva Espinosa-Padilla
- Mario Ernesto Cruz-MuñozMCMario Ernesto Cruz-Muñoz
- 19 January 2026
- journal article
- Published by Elsevier in Human Immunology
- Vol. 87 (3) , 111655
Abstract
No abstract availableKeywords
Funding Information
- Universidad Autónoma del Estado de Morelos
This publication has 8 references indexed in Scilit:
- MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter CohortThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- A large single‐center cohort of bare lymphocyte syndrome: Immunological and genetic features in TurkeyScandinavian Journal of Immunology, 2023
- Improved transplant survival and long-term disease outcome in children with MHC class II deficiencyBlood, 2020
- Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican DescentJournal of Clinical Immunology, 2015
- MHC class I and II deficienciesJournal of Allergy and Clinical Immunology, 2014
- When the Lymphocyte Loses Its ClothesImmunity, 2003
- The Bare Lymphocyte Syndrome and the Regulation of MHC ExpressionAnnual Review of Immunology, 2001
- Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group BImmunogenetics, 2000